AstraZeneca Plc got a boost from a long-time shareholder and one of its biggest institutional stockholders after other investors criticized the drugmaker for spurning Pfizer Inc.’s 69-billion-pound ($117 billion) takeover offer.
Emerging-market stocks will outperform those of developed nations next year as monetary policy becomes more “accommodative,” according to Fidelity Worldwide Investment. Citigroup Inc. said developing shares may advance about 28 percent by the end of 2012.
Gartmore Group Ltd., the U.K. money manager that first sold shares in December, fell the most in seven months in London after the firm said it’s weighing a sale or merger, and fund manager Roger Guy said he will retire.
Xstrata Plc investors say a potential 250 million-pound ($385 million) payout to 73 managers and executives of the mining company after its takeover by Glencore International Plc is “insensitive” and “unacceptable.”
Barclays Plc saved itself 25.5 million pounds ($40 million) in fines by moving first to settle a probe over the rigging of global interest rates. In return, it has lost three top executives, $5 billion of market value and sparked a government inquiry.